Open AccessP1069: RETROSPECTIVE COMPARISON OF PATIENT OUTCOMES ON PACRITINIB VERSUS RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS AND THROMBOCYTOPENIA
Author(s) -
Harrison C.,
Bose P.,
Mesa R.,
Gerds A.,
Oh S.,
Kiladjian J.J.,
GarcíaGutierrez V.,
Vannucchi A.,
Scheid C.,
Sobas M.,
Verstovsek S.,
Buckley S.,
RomanTorres K.,
Mascarenhas J.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000847144.39334.7c
Subject(s) - ruxolitinib , medicine , myelofibrosis , population , adverse effect , anemia , bone marrow , environmental health